Dry Powder Formulation Comprising A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation

Patent No. EP2806855 (titled "Dry Powder Formulation Comprising A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation") was filed by Chiesi Farmaceutici on Jan 23, 2013. The application was issued on Jul 11, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ZBM PATENTSApr 10, 2019ZBM PATENTS ZEA

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2806855

CHIESI FARMACEUTICI
Application Number
EP13704372A
Filing Date
Jan 23, 2013
Status
Opposition Rejected
Jun 2, 2023
Publication Date
Jul 11, 2018